ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitorDong Li, Håkon Håkonarson, Michael March et al.|Nature Medicine|2019Cited by 221
Pathogenic variant in EPHB4 results in central conducting lymphatic anomalyDong Li, Håkon Håkonarson, Rosetta Chiavacci et al.|Human Molecular Genetics|2018Cited by 100
Genomic profiling informs diagnoses and treatment in vascular anomaliesDong Li, Håkon Håkonarson, Sarah E. Sheppard et al.|Nature Medicine|2023Cited by 63
Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibitionSarah E. Sheppard, Håkon Håkonarson, Michael March et al.|JCI Insight|2023Cited by 37
Missense Mutations in NKAP Cause a Disorder of Transcriptional Regulation Characterized by Marfanoid Habitus and Cognitive ImpairmentSarah K. Fiordaliso, Kosuke Izumi, Aiko Iwata‐Otsubo et al.|The American Journal of Human Genetics|2019Cited by 18